For this purpose, tumor mRNA expression data from the TCGA-STAD were acquired and separated as 408 tumor samples into 2 groups: SMPDL3B-high and SMPDL3B-low, using the median expression of SMPDL3B as a cutoff value. This evidence concerns the gene SMPDL3B and neoplasm.